Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management

Our aim in this review is to discuss current treatments and investigational products and their effect on patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) and provide suggestions for monitoring disease progression and treatment efficacy.

Detalles Bibliográficos
Autores principales: Vélez-Santamaría, Valentina, Nedkova-Hristova, Velina, Morales de la Prida, Moisés, Casasnovas, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789700/
https://www.ncbi.nlm.nih.gov/pubmed/36573111
http://dx.doi.org/10.2147/IJGM.S338430
_version_ 1784859011017867264
author Vélez-Santamaría, Valentina
Nedkova-Hristova, Velina
Morales de la Prida, Moisés
Casasnovas, Carlos
author_facet Vélez-Santamaría, Valentina
Nedkova-Hristova, Velina
Morales de la Prida, Moisés
Casasnovas, Carlos
author_sort Vélez-Santamaría, Valentina
collection PubMed
description Our aim in this review is to discuss current treatments and investigational products and their effect on patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) and provide suggestions for monitoring disease progression and treatment efficacy.
format Online
Article
Text
id pubmed-9789700
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97897002022-12-25 Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management Vélez-Santamaría, Valentina Nedkova-Hristova, Velina Morales de la Prida, Moisés Casasnovas, Carlos Int J Gen Med Review Our aim in this review is to discuss current treatments and investigational products and their effect on patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) and provide suggestions for monitoring disease progression and treatment efficacy. Dove 2022-12-20 /pmc/articles/PMC9789700/ /pubmed/36573111 http://dx.doi.org/10.2147/IJGM.S338430 Text en © 2022 Vélez-Santamaría et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Vélez-Santamaría, Valentina
Nedkova-Hristova, Velina
Morales de la Prida, Moisés
Casasnovas, Carlos
Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
title Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
title_full Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
title_fullStr Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
title_full_unstemmed Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
title_short Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
title_sort hereditary transthyretin amyloidosis with polyneuropathy: monitoring and management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789700/
https://www.ncbi.nlm.nih.gov/pubmed/36573111
http://dx.doi.org/10.2147/IJGM.S338430
work_keys_str_mv AT velezsantamariavalentina hereditarytransthyretinamyloidosiswithpolyneuropathymonitoringandmanagement
AT nedkovahristovavelina hereditarytransthyretinamyloidosiswithpolyneuropathymonitoringandmanagement
AT moralesdelapridamoises hereditarytransthyretinamyloidosiswithpolyneuropathymonitoringandmanagement
AT casasnovascarlos hereditarytransthyretinamyloidosiswithpolyneuropathymonitoringandmanagement

Ejemplares similares